Israel Englander Agios Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 5,049 shares of AGIO stock, worth $220,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,049

Previous 300,203 98.32%

Holding current value

$220,388

Previous $9.98 Million 97.98%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$34.37 - $40.61 $10.1 Million - $12 Million	-295,154 Reduced 98.32%	5,049 $202,000
Q2 2025 Aug 14, 2025	BUY	$24.53 - $35.75 $6.06 Million - $8.83 Million	247,130 Added 465.64%	300,203 $9.98 Million
Q1 2025 May 15, 2025	BUY	$29.3 - $35.9 $904,696 - $1.11 Million	30,877 Added 139.11%	53,073 $1.56 Million
Q4 2024 Feb 14, 2025	SELL	$32.86 - $61.64 $1.83 Million - $3.44 Million	-55,734 Reduced 71.52%	22,196 $729,000
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $1.93 Million - $2.33 Million	46,843 Added 150.68%	77,930 $3.46 Million

Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $454,960 - $806,378	-16,514 Reduced 34.69%	31,087 $1.34 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $69,119 - $112,854	3,242 Added 7.31%	47,601 $1.39 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $2.59 Million - $3.18 Million	-129,646 Reduced 74.51%	44,359 $987,000
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $2.4 Million - $3.28 Million	112,316 Added 182.07%	174,005 $4.93 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $1.34 Million - $1.91 Million	61,689 New	61,689 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $1.28 Million - $2.23 Million	-65,409 Reduced 52.82%	58,421 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $1.42 Million - $2.61 Million	82,995 Added 203.24%	123,830 $2.75 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $1.32 Million - $1.72 Million	-49,404 Reduced 54.75%	40,835 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $2.27 Million - $3.82 Million	76,651 Added 564.11%	90,239 $2.97 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $569,608 - $790,549	13,588 New	13,588 $627,000
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $12.2 Million - $14.3 Million	-233,815 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $3.12 Million - $4.05 Million	-70,450 Reduced 23.15%	233,815 $12.1 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $7.52 Million - $10.5 Million	226,363 Added 290.57%	304,265 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $1.79 Million - $2.96 Million	-52,850 Reduced 40.42%	77,902 $2.73 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $5.07 Million - $7.87 Million	-147,176 Reduced 52.95%	130,752 $6.99 Million
Q1 2020 May 14, 2020	SELL	$31.52 - $53.81 $2.15 Million - $3.67 Million	-68,275 Reduced 19.72%	277,928 $9.86 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $4 Million - $6.73 Million	133,095 Added 62.45%	346,203 $16.5 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $5.49 Million - $8.41 Million	169,566 Added 389.43%	213,108 $6.9 Million
Q2 2019 Aug 15, 2019	BUY	$46.17 - $68.1 $2.01 Million - $2.97 Million	43,542 New	43,542 $2.17 Million
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $9.91 Million - $14.6 Million	-215,902 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $6.86 Million - $12.3 Million	160,493 Added 289.65%	215,902 $9.96 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $3.97 Million - $5.09 Million	55,409 New	55,409 $4.27 Million

Others Institutions Holding AGIO

# of Institutions

256

Shares Held

63.8M

Call Options Held

2.06M

Put Options Held

911K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.39B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account